Posted on 08/23/2021 7:49:21 AM PDT by Berlin_Freeper
Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments.
Pfizer will pay $18.50 for each share of Trillium Therapeutics Inc., or more than double the stock’s 60-day weighted average price.
Trillium has no products on the market. Its potential treatments include biologics that aim to prime a patient’s immune system to detect and destroy cancer cells.
Its two lead candidates are in early-stage testing and focus on hematology. That includes blood, bone marrow and lymph node cancers like leukemia or lymphoma.
The deal announced Monday will need approval from Trillium shareholders.
(Excerpt) Read more at abcnews.go.com ...
Very smart move, as thier vacine destroys T cells that help prevent cancer. Take profits from the vacine...very, very smart move. Diabolical, but smart.
Yes, there it is.
Buy, and bury?
Well, as of 1 pm, despite spending billions, Pfizer’s stock is up.
I read they have made $35 billion from their covid vaccine. I’m sure the stock is up due to today’s FDA approval.
Trillium (TRIL) is up 189%.
I read the title wrong. haha
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.